Multi Cancer Early Detection Market Sales Revenue and Key Drivers Analysis Research Report by 2030
The global MCED market size was USD 791.6 Million in 2021 and is expected to register a revenue CAGR of 15.8% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of cancer and extensive R&D for development of MCED are major factors driving market revenue growth. With increasing prevalence of cancer, early cancer detection is crucial, since later-stage detection results in a fewer treatment options and often worse outcomes. Newer and more creative multi-cancer screening technology can have the ability to identify more tumors at earlier stages, while additional study is required to evaluate impact on outcomes. Multi-cancer early detection blood-based diagnostics are now being developed by a number of private and academic organizations. According to published data, some of these tests can simultaneously screen for a variety of malignancies including some rare tumors. Comprehensive coverage of aspects such as market potential, ...